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Edited by Giulio Superti-FurgaAbstract TRPM6 and TRPM7 encode channel-kinases. While
these channels share electrophysiological properties and cellular
functions, TRPM6 and TRPM7 are non-redundant genes raising
the possibility that the kinases have distinct substrates. Here, we
demonstrate that TRPM6 and TRPM7 phosphorylate the
assembly domain of myosin IIA, IIB and IIC on identical resi-
dues. Whereas phosphorylation of myosin IIA is restricted to
the coiled-coil domain, TRPM6 and TRPM7 also phosphorylate
the non-helical tails of myosin IIB and IIC. TRPM7 does not
phosphorylate eukaryotic elongation factor-2 (eEF-2) and myo-
sin II is a poor substrate for eEF-2 kinase. In conclusion,
TRPM6 and TRPM7 share exogenous substrates among them-
selves but not with functionally distant a-kinases.
Structured summary:
MINT-6700314:
GNA1 (uniprotkb:Q96EK6) and GNA1 (uniprotkb:Q96EK6)
bind (MI:0407) by X-ray crystallography (MI:0114)
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Phosphorylation1. Introduction
TRPM6 and TRPM7 are bifunctional proteins encoding a
TRP cation channel fused to an a-kinase and represent the
only two proteins in the mammalian genome with this partic-
ular architecture. A critical issue in understanding the biolog-Abbreviations: eEF-2, eukaryotic elongation factor-2; LC-MS/MS
nanoliquid chromatography–tandem mass spectrometry; PTM, pos
translational modiﬁcation; WT, wild-type
*Corresponding author. Fax: +31 24 3666352.
E-mail address: FN.vanleeuwen@cukz.umcn.nl (F.N. van Leeuwen).
0014-5793/$34.00  2008 Federation of European Biochemical Soci
doi:10.1016/j.febslet.2008.07.043,
t-
eties. Puical function of TRPM6 and TRPM7 is to identify the sub-
strates for each kinase.
Within the mammalian a-kinase family, TRPM6 and
TRPM7 are most closely related to each other. In addition
to similarity in primary structure, TRPM6 and TRPM7 have
comparable electrophysiological properties as well as cellular
functions. Physiological Mg2+ and Mg2+-nucleotide concentra-
tions inhibit TRPM6 and TRPM7 channels [1,2] and these
channels play a key role in Mg2+ homeostasis [3–5]. However,
TRPM6 and TRPM7 also have unique roles in human biol-
ogy. Overexpression of TRPM6 cannot rescue cell growth ar-
rest due to ablation of TRPM7 [6] and the disease familial
hypomagnesemia with secondary hypocalcemia, which is
caused by mutations of TRPM6, progresses despite the expres-
sion of TRPM7 in both the intestine and kidney [3,4]. Thus,
TRPM6 and TRPM7 have unique functions even though they
share many structural and electrophysiological features. Are
these functional diﬀerences related to a distinct set of sub-
strates for each kinase?
In contrast to channel function, little is known about the
substrates for TRPM6 and TRPM7 kinases. To date, no exog-
enous substrates have been identiﬁed for TRPM6, whereas
TRPM7 phosphorylates annexin I and myosin IIA heavy
chain [7–9]. In addition to myosin IIA, mammalian cells also
express myosin IIB and IIC. These three non-muscle myosin
II isoforms are well conserved throughout the entire protein
and share certain cellular functions but there is increasing evi-
dence for non-redundant roles for each isoform [10]. Whether
TRPM7 phosphorylates the heavy chains of all three myosin II
isoforms remains unknown. Therefore, we compared the sub-
strate speciﬁcity of TRPM6, TRPM7 and a functionally dis-
tant a-kinase, eukaryotic elongation factor-2 (eEF-2) kinase,
by assessing the phosphorylation of non-muscle myosin IIA,
IIB and IIC.2. Materials and methods
2.1. Constructs
Cloning of wild-type (WT) and kinase-dead HA-TRPM7-C and WT
HA-TRPM6-C in pcDNA3, eEF-2 kinase in pGEX-2T and the
TRPM7 kinase domain (TRPM7-cat) in pMAL-p2x were previouslyblished by Elsevier B.V. All rights reserved.
Fig. 1. Phosphorylation of myosin IIA, IIB and IIC heavy chains by TRPM7. (A) A schematic diagram of the regions of myosin IIA, IIB and IIC
heavy chains expressed as GST-fusion proteins. The start and end amino acid is indicated on either side of the line. Above the line is the total number
of threonine and serine residues within the fragment. (B) TRPM7 phosphorylates the COOH terminus of myosin IIA, IIB and IIC heavy chains. Top,
coomassie blue stained gel; middle, autoradiogram of GST-myosin II; bottom, autoradiogram of autophosphorylated TRPM7. (C) Quantiﬁcation of
myosin II phosphorylation by TRPM7. The level of 32P incorporation after a 30 min incubation with TRPM7 is reported relative to the degree of
myosin IIA phosphorylation which was set to 1. (D) Deletion of the non-helical tail from the COOH terminus of myosin IIB and IIC heavy chains
reduces their phosphorylation to levels observed in myosin IIA. Top, coomassie blue stained gel; middle, autoradiogram of GST-myosin II; bottom,
autoradiogram of autophosphorylated TRPM7.
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were generated by inserting PCR products into the BamHI–EcoRI sites
in the pGEX-1N vector. All constructs were veriﬁed by DNA sequenc-
ing.
2.2. Cell culture
HEK293 cells were cultured in DMEM medium with 10% FCS.
Cells were transfected using lipofectamine (Roche).
2.3. Puriﬁcation of recombinant proteins
GST-myosin II proteins were expressed in Escherichia coli and puri-
ﬁed by aﬃnity chromatography on a glutathione-sepharose column
using standard methods. HA-TRPM6-C and HA-TRPM7-C kinases
were puriﬁed from mammalian cells by immunoprecipitation [11].
TRPM7-cat, eEF-2 kinase and eEF-2 were puriﬁed as previously de-
scribed [12,13]. The identity and integrity of the recombinant proteins
were veriﬁed by mass spectrometry.
2.4. In vitro kinase assays
TRPM6 and TRPM7 kinases (20 ng) were dissolved in 50 ll IVK
buﬀer (50 mM HEPES, pH 7.0, 4 mM MnCl2, 2 mM DTT) with
2 lg of GST-fusion protein. Kinase reactions were initiated by adding
0.1 mM ATP in combination with 5 lCi of [c-32P]ATP and allowed to
proceed for 30 min at 30 C. Activity of eEF-2K was assayed as previ-
ously described [12]. The reactions were stopped by adding Laemmli
buﬀer containing 40 mM EDTA and subjected to SDS–PAGE. Phos-
phorylated proteins were detected by autoradiography and quantiﬁed
by phosphorimager analysis.
2.5. Mass spectrometry
Peptide identiﬁcation experiments were performed using a nano-
HPLC Agilent 1100 nanoﬂow system connected online to a 7-T linear
ion trap Ion Cyclotron Resonance Fourier Transform mass spectrom-
eter (Thermo Fisher, Bremen, Germany). Veriﬁcation and site map-
ping of phosphorylated peptides was performed using the post-
translational modiﬁcation (PTM) algorithm implemented in MSQuant
according to the procedure of Olsen et al. [14]. Phosphopeptides were
identiﬁed with a 99%-signiﬁcance threshold when the sum of the Mas-
cot and PTM score was higher than 28 [14]. The delta PTM score, the
diﬀerence between the highest and second highest PTM score, was setto be larger than 8.0 to exclusively report peptides with a mapped
phosphorylation site. As a ﬁnal veriﬁcation step, peptides containing
phosphorylation sites occurring only once or twice were veriﬁed by
manual inspection of the MS2 and MS3 spectra.3. Results
TRPM7 phosphorylates the COOH extremity of the myosin
IIA heavy chain [9]. To examine whether TRPM7 also phos-
phorylates myosin IIB and IIC heavy chains, regions homolo-
gous to myosin IIA were puriﬁed as GST-fusion proteins (Fig.
1A). Incubation of these proteins with TRPM7 led to the phos-
phorylation of all three myosin II isoforms (Fig. 1B). Like
myosin IIA, the phosphorylation sites in the myosin IIB and
IIC heavy chains are located within the COOH terminus since
upstream regions of the coiled-coil domain were not phosphor-
ylated by TRPM7. However, after a 30 min reaction, 32P
incorporation by TRPM7 into myosin IIB and IIC was
approximately 10-fold greater than for myosin IIA (Fig. 1C).
Sequence alignment of the myosin II isoforms revealed that
the helical tail is highly conserved between all three isoforms
but the non-helical tail diﬀers signiﬁcantly in length and se-
quence (see Fig. 2B). The non-helical tails of myosin IIB and
IIC contain a short stretch of amino acids rich in serines and
threonines that is absent in the myosin IIA isoform. We there-
fore generated GST-fusion proteins where the helical and non-
helical tails were separated from one another. The myosin IIB
and IIC non-helical tails were phosphorylated by TRPM7,
whereas the myosin IIA non-helical tail was not phosphory-
lated (Fig. 1D). Moreover, removal of the non-helical tail from
the COOH terminus of myosin IIB and IIC reduced the levels
of phosphorylation to those observed in myosin IIA (Fig. 1D).
Thus, diﬀerential phosphorylation of the non-helical tail by
Fig. 2. Mapping of TRPM7 phosphorylation sites in myosin IIA, IIB and IIC heavy chains by nanoLC-MS/MS. (A) A representative MS2 and MS3
spectra for a myosin IIB peptide phosphorylated on Ser-1935 (m/z observed of parent ion was 537.7342, mass accuracy 0.38 ppm, +2 charge state; NL
indicates neutral loss of H3PO4 which triggers acquisition of MS
3 spectrum). The b+-ion series is indicated in red, whereas the y+-ion series is blue. (B)
Alignment of the COOH termini of myosin IIA, IIB and IIC heavy chains. The helical tail is in normal font and the non-helical tail in italic. Residues
phosphorylated by TRPM7 are in bold and underlined.
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myosin II isoforms.
TRPM7 phosphorylates mainly serines in myosin IIA and
IIB but threonines in myosin IIC (data not shown). We
mapped the phosphorylation sites in all three non-muscle iso-
forms by mass spectrometry (Fig. 2 and Supplemental Data).
TRPM7 phosphorylates Thr1800, Ser1803 and Ser1808 in
the coiled-coil domain of myosin IIA. This part of the heavy
chain is also phosphorylated in myosin IIB and IIC. In con-
trast to Ser1803, which is only conserved in myosin IIB
(S1812), Ser1808 is conserved and phosphorylated in both
myosin IIB (T1817) and IIC (T1833). In addition to the
coiled-coil domain, TRPM7 phosphorylates numerous serines
in the myosin IIB and threonines in the myosin IIC non-helical
tails. Nanoliquid chromatography–tandem mass spectrometry
(LC-MS/MS) analysis determined with high probability that
multiple residues in both myosin IIB and IIC are phosphory-
lated by TRPM7 in this region.
Like TRPM7, TRPM6 phosphorylates the COOH terminus
of the diﬀerent myosin II isoforms (Fig. 3A) with a 10-fold
greater incorporation of 32P in myosin IIB and IIC. Again, this
diﬀerence is due to the phosphorylation of the non-helical tails
of myosin IIB and IIC by TRPM6 (data not shown). Our LC-
MS/MS experiments indicated that TRPM6 phosphorylates
the same sites as TRPM7 in the diﬀerent myosin II isoforms
(data not shown). Moreover, mutation of the phosphosites
Thr1800, Ser1803 and Ser1808 to alanine reduced the phos-
phorylation of myosin IIA by TRPM6 and TRPM7 to back-
ground levels (Fig. 3B). Finally, we found that TRPM7cannot phosphorylate eEF-2 and conversely, eEF-2 kinase
poorly phosphorylates non-muscle myosin II isoforms, show-
ing that these distantly related members of the a-kinase family
each phosphorylate speciﬁc substrates in vitro (Fig. 4).4. Discussion
An important conclusion from our investigation is that
TRPM6 and TRPM7 share exogenous substrates with them-
selves but not with a-kinases having distantly related functions
such as eEF-2 kinase. We demonstrated that TRPM6 and
TRPM7 phosphorylate the diﬀerent myosin II isoforms on
identical residues. Moreover, TRPM7 failed to phosphorylate
eEF-2 and eEF-2 kinase only weakly phosphorylated myosin
II. While the diﬀerences between TRPM7 and eEF-2 kinase
are consistent with a recent study on peptide substrate speciﬁc-
ity of a-kinases [15], our results contrast with another study by
Schmitz et al. [6] who concluded that TRPM6 and TRPM7
have diﬀerent substrate speciﬁcities since TRPM6 cross-phos-
phorylates TRPM7 but not vice versa. Our studies diﬀer in
two important ways: (1) we examined the phosphorylation of
unrelated exogenous substrates, whereas Schmitz et al. [6]
investigated the level of cross-phosphorylation by both kinases
and (2) we measured the incorporation of 32P into our sub-
strates while Schmitz et al. [6] used a pan phospho-threonine
antibody to detect phosphorylation. TRPM6 and TRPM7 un-
dergo massive autophosphorylation of the Ser/Thr-rich do-
main predominantly on serine residues [6,11,13]. Therefore,
Fig. 3. Myosin II phosphorylation by TRPM6. (A) TRPM6 phos-
phorylates the COOH terminus of myosin IIA, IIB and IIC. (B)
TRPM6 phosphorylates the same residues in myosin IIA as TRPM7.
Thr1800, Ser1803 and Ser1808 were mutated to alanine to generate
GST-myosin IIA COOH 3xA (aa 1795–1960).
Fig. 4. Preferential phosphorylation of myosin II by TRPM7 and
eEF-2 by eEF-2 kinase. Kinase reactions consisted of TRPM7-cat and
eEF-2 kinase with either GST-myosin IIB COOH or eEF-2.
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vide an accurate account of the extent of cross-phosphoryla-
tion by the kinases. Our data clearly demonstrate that
TRPM6 and TRPM7 share substrate speciﬁcity when it comes
to phosphorylating exogenous substrates.
Although TRPM6 and TRPM7 phosphorylate all three non-
muscle myosin II isoforms, we observed important diﬀerences
between substrates. Most notably, both TRPM6 and TRPM7
phosphorylate the non-helical tail of myosin IIB and IIC but
not that of myosin IIA. The presence of additional phosphoac-
ceptor sites in this region of myosin IIB and IIC led to a 10-
fold increase in 32P incorporation in comparison to myosin
IIA under the kinase reaction conditions used in this investiga-
tion (single time-point and substrate concentration). We would
like to emphasize that these results do not necessarily mean
that myosin IIB and IIC are better substrates for TRPM6
and TRPM7 than myosin IIA, as the phosphorylation occurs
on diﬀerent residues and important regulatory components
present in mammalian cells may be absent from the in vitro ki-
nase reactions. Additional experiments will be required to
establish the circumstances under which TRPM6 and TRPM7
phosphorylate the diﬀerent myosin II isoforms in mammalian
cells.
The phosphorylation of the non-helical tails of myosin IIB
and IIC by TRPM6 and TRPM7 was unexpected since a-ki-
nases are thought to preferentially phosphorylate amino acids
in the context of an a-helix, a distinguishing feature of this
atypical protein kinase family [16]. However, characterization
of a peptide library demonstrated that TRPM6 and TRPM7
preferentially phosphorylate peptides with a consensus se-
quence that adopts an a-helix structure under speciﬁc solvent
conditions. Taking this information into consideration, an
algorithm was designed to predict TRPM6 and TRPM7 phos-
phorylation sites in its substrates (Ryazanov et al., manuscript
in preparation). This algorithm accurately predicted the phos-
phorylation of the myosin IIB and IIC non-helical tails. Cur-
rently, we are investigating the possibility that the TRPM6
and TRPM7 kinase domains assist in the shaping of these pep-
tides into a-helices for subsequent phosphorylation.
Elucidation of the pathways that control myosin II function
is critical to our understanding of the pathogenesis of human
diseases involving defects in mechanobiology [10]. Recently,
we demonstrated that TRPM7 promotes actomyosin relaxa-
tion in mammalian cells by phosphorylating myosin IIA
[8,9]. Here, we further extend on these ﬁndings by showing that
TRPM6 and TRPM7 phosphorylate the assembly domain of
all three non-muscle myosin II isoforms. Both channel-kinases
phosphorylate the same stretch of amino acids in the helical
domain of all three myosin II isoforms. We recently demon-
strated that this region regulates the assembly of myosin IIA
ﬁlaments [9]. In addition to the helical domain, TRPM6 and
TRPM7 phosphorylate a cluster of serines and threonines in
the myosin IIB and IIC non-helical tails, respectively. This
stretch of serine residues in myosin IIB is phosphorylated in
vivo by PKCf in response to EGF stimulation and is a critical
determinant in regulating ﬁlament assembly and protein local-
ization to the cortical cytoskeleton [17]. This raises the intrigu-
ing possibility that TRPM6 and TRPM7 may synergize with
PKCf to regulate myosin IIB ﬁlament stability.
In conclusion, our results are consistent with a role for
TRPM6 and TRPM7 in regulating actomyosin contractility
by phosphorylating myosin IIA, IIB and IIC. Establishing
K. Clark et al. / FEBS Letters 582 (2008) 2993–2997 2997the cellular context in which TRPM6 and TRPM7 control the
activity of these diﬀerent myosin II isoforms and its link to
magnesium homeostasis remain challenges for future research.
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